MyAverix Finance
US · Healthcare
Virbac SA (VRBCF)
Drug Manufacturers - General
Virbac SA (VRBCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VRBCF
Virbac SA (VRBCF) — FAQ
What is VRBCF's P/E ratio?
The price-to-earnings (P/E) ratio for Virbac SA (VRBCF) is 18.00 (data as of 2026-03-25).
Does Virbac SA pay a dividend?
Dividend yield is not available in the current snapshot for Virbac SA (VRBCF). Check the MyAverix Finance app for the latest dividend data.
What sector is Virbac SA in?
Virbac SA (VRBCF) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is VRBCF listed on?
VRBCF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.